As of 2025-05-27, the EV/EBITDA ratio of Sihuan Pharmaceutical Holdings Group Ltd (460.HK) is -161.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 460.HK's latest enterprise value is 4,897.41 mil HKD. 460.HK's TTM EBITDA according to its financial statements is -30.24 mil HKD. Dividing these 2 quantities gives us the above 460.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 21.2x | 18.8x |
| Forward P/E multiples | 11.4x - 12.5x | 12.0x |
| Fair Price | 0.28 - 0.95 | 0.60 |
| Upside | -67.8% - 8.7% | -31.3% |
| Date | EV/EBITDA |
| 2025-05-23 | -154.09 |
| 2025-05-22 | -159.69 |
| 2025-05-21 | -140.07 |
| 2025-05-20 | -134.46 |
| 2025-05-19 | -123.25 |
| 2025-05-16 | -92.41 |
| 2025-05-15 | -89.61 |
| 2025-05-14 | -98.02 |
| 2025-05-13 | -98.02 |
| 2025-05-12 | -98.02 |
| 2025-05-09 | -100.82 |
| 2025-05-08 | -103.63 |
| 2025-05-07 | -106.43 |
| 2025-05-06 | -112.04 |
| 2025-05-02 | -112.04 |
| 2025-04-30 | -106.43 |
| 2025-04-29 | -109.23 |
| 2025-04-28 | -98.02 |
| 2025-04-25 | -89.61 |
| 2025-04-24 | -89.61 |
| 2025-04-23 | -86.81 |
| 2025-04-22 | -89.61 |
| 2025-04-17 | -81.20 |
| 2025-04-16 | -81.20 |
| 2025-04-15 | -84.00 |
| 2025-04-14 | -81.20 |
| 2025-04-11 | -81.20 |
| 2025-04-10 | -75.59 |
| 2025-04-09 | -69.99 |
| 2025-04-08 | -64.38 |
| 2025-04-07 | -61.58 |
| 2025-04-03 | -89.61 |
| 2025-04-02 | -89.61 |
| 2025-04-01 | -75.59 |
| 2025-03-31 | -64.38 |
| 2025-03-28 | -72.79 |
| 2025-03-27 | -72.79 |
| 2025-03-26 | -75.59 |
| 2025-03-25 | -75.59 |
| 2025-03-24 | -78.40 |
| 2025-03-21 | -84.00 |
| 2025-03-20 | -89.61 |
| 2025-03-19 | -84.00 |
| 2025-03-18 | -81.20 |
| 2025-03-17 | -75.59 |
| 2025-03-14 | -72.79 |
| 2025-03-13 | -69.99 |
| 2025-03-12 | -72.79 |
| 2025-03-11 | -72.79 |
| 2025-03-10 | -72.79 |